Last reviewed · How we verify
Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age treatment landscape brief
- Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age treatment updates RSS
Frequently asked questions about Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age
What drugs treat Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age?
Tracked treatments include DTacP-IPV combined vaccine (TETRAXIM™).
What is the treatment for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age?
Standard treatment for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age includes DTacP-IPV combined vaccine (TETRAXIM™). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age patent cliff · Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in children 6 weeks through 6 years of age CI report
- Treatment: DTacP-IPV combined vaccine (TETRAXIM™) · Sanofi
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing